| Drug Name: | Cladribine (4291-63-8) |
|---|---|
| PubChem ID: | 20279 |
| SMILES: | C1[C@@H]([C@H](O[C@H]1N2C=NC3=C2N=C(N=C3N)Cl)CO)O |
| InchiKey: | PTOAARAWEBMLNO-KVQBGUIXSA-N |
| Therapeutic Category: | Antineoplastic Agents, Immunologic Factors, Immunosuppressive Agents |
| Molecular Weight (dalton) | : | 285.691 |
| LogP | : | -0.2974 |
| Ring Count | : | 2 |
| Hydrogen Bond Acceptor Count | : | 8 |
| Hydrogen Bond Donor Count | : | 3 |
| Total Polar Surface Area | : | 119.31 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category